Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CISPLATIN\PACLITAXEL: 19 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
19
Total FAERS Reports
4 (21.1%)
Deaths Reported
0
Hospitalizations
19
As Primary/Secondary Suspect
8
Life-Threatening
5
Disabilities

First Report: 20180427 · Latest Report: 20180427

What Are the Most Common CISPLATIN\PACLITAXEL Side Effects?

#1 Most Reported
Lymphangioleiomyomatosis
8 reports (42.1%)
#2 Most Reported
Acute myeloid leukaemia
8 reports (42.1%)
#3 Most Reported
White blood cell count increased
5 reports (26.3%)

All CISPLATIN\PACLITAXEL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Acute myeloid leukaemia 8 42.1% 4 0
Lymphangioleiomyomatosis 8 42.1% 4 0
Blast cells present 5 26.3% 3 0
Haematocrit decreased 5 26.3% 3 0
Haemoglobin decreased 5 26.3% 3 0
Mean cell haemoglobin decreased 5 26.3% 3 0
Mean cell volume abnormal 5 26.3% 3 0
Neutrophil percentage decreased 5 26.3% 3 0
Platelet count decreased 5 26.3% 3 0
Red cell distribution width increased 5 26.3% 3 0
Second primary malignancy 5 26.3% 0 0
White blood cell count increased 5 26.3% 0 0

Who Reports CISPLATIN\PACLITAXEL Side Effects? Age & Gender Data

Gender: 85.7% female, 14.3% male. Average age: 71.0 years. Most reports from: CA. View detailed demographics →

Is CISPLATIN\PACLITAXEL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2018 8 4 0

View full timeline →

What Is CISPLATIN\PACLITAXEL Used For?

IndicationReports
Product used for unknown indication 8
Non-hodgkin's lymphoma 5

Official FDA Label for CISPLATIN\PACLITAXEL

Official prescribing information from the FDA-approved drug label.